Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acasti Pharma
(NQ:
ACST
)
0.9257
-0.0243 (-2.56%)
Streaming Delayed Price
Updated: 3:57 PM EDT, May 20, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Acasti Pharma
< Previous
1
2
Next >
Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine
May 18, 2022
Via
Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact
May 18, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
May 09, 2022
Good morning, trader! We're starting off another week of trading with an overview of the biggest pre-market stock mover for Monday!
Via
InvestorPlace
20 Stocks Moving in Monday's Pre-Market Session
May 09, 2022
Gainers Decisionpoint Systems, Inc. (NASDAQ: DPSI) shares rose 32.3% to $8.85 in pre-market trading after declining over 4% on Friday.
Via
Benzinga
Earnings Scheduled For February 14, 2022
February 14, 2022
Companies Reporting Before The Bell • Weber (NYSE:WEBR) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million.
Via
Benzinga
Acasti Pharma's Earnings Outlook
February 11, 2022
Acasti Pharma (NASDAQ:ACST) is set to give its latest quarterly earnings report on Monday, 2022-02-14. Here's what investors need to know before the announcement. Analysts estimate that Acasti Pharma...
Via
Benzinga
Acasti Pharma: Bouncing Back With a New Drug Pipeline
January 04, 2022
Picture credit: Louis Reed on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
54 Biggest Movers From Thursday
December 27, 2021
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
December 23, 2021
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK....
Via
Benzinga
BLITF Stock: 7 Thing to Know About Mobile Gaming Play i3 Interactive as Shares Rocket Today
December 23, 2021
i3 Interactive (BLITF) stock is rising higher on heavy trading Thursday despite a lack of news from the mobile gambling company.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 23, 2021
Good morning, trader! Christmas is almost here but were aren't slowing down as we dive into the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
18 Stocks Moving in Thursday's Pre-Market Session
December 23, 2021
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) rose 26.5% to $1.86 in pre-market trading. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic...
Via
Benzinga
50 Biggest Movers From Yesterday
December 23, 2021
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares surged 53.4% to settle at $16.31 on Wednesday. Acasti Pharma Inc. (NASDAQ: ACST) jumped 52.3% to close at $1.69 on...
Via
Benzinga
ACST Stock Price Predictions: Why One Analyst Sees Acasti Rocketing to $6
December 22, 2021
After an Oppenheimer upgrade, shares of ACST stock are soaring higher by more than 25%. Why exactly is the investment firm bullish?
Via
InvestorPlace
Mid-Afternoon Market Update: CalAmp Drops After Q3 Results; Red Cat Holdings Shares Surge
December 22, 2021
Toward the end of trading Wednesday, the Dow traded up 0.51% to 35,674.84 while the NASDAQ rose 0.53% to 15,422.40. The S&P also rose, gaining 0.60% to 4,677.06. The U....
Via
Benzinga
Mid-Day Market Update: Nasdaq Rises Over 100 Points; Allakos Shares Plunge
December 22, 2021
Midway through trading Wednesday, the Dow traded up 0.41% to 35,637.05 while the NASDAQ rose 0.80% to 15,463.85. The S&P also rose, gaining 0.67% to 4,680.45. The U.S. has the...
Via
Benzinga
32 Stocks Moving In Wednesday's Mid-Day Session
December 22, 2021
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 31.7% to $2.41 after the company announced it was awarded a multiple award blanket purchase agreement by the United...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021
December 22, 2021
Upgrades According to Loop Capital, the prior rating for Williams-Sonoma Inc (NYSE:
Via
Benzinga
See Why Acasti Pharma Shares Are Trading Over 20% Higher?
December 22, 2021
Oppenheimer initiated coverage of Acasti Pharma Inc (NASDAQ: ACST) with an Outperform rating and $6 price target. The analyst sees over 400% upside for...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 22, 2021
We've reached the halfway point of the week and we're starting it with an overview of the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
December 22, 2021
Gainers BioRestorative Therapies, Inc. (NASDAQ: BRTX) rose 48.1% to $6.77 in pre-market trading after the company entered into a Master Service Agreement with PRC Clinical,...
Via
Benzinga
Acasti Pharma's Hemorrhage Candidate Shows Encouraging PK Profile In Healthy Volunteers
December 02, 2021
Acasti Pharma Inc (NASDAQ: ACST) has announced interim results from its pivotal pharmacokinetic (PK) bridging study of GTX-104 for Subarachnoid Hemorrhage. Based...
Via
Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy Incremental COVID-19 Vaccines From Moderna And Pfizer-...
Via
Benzinga
Exposures
COVID-19
55 Biggest Movers From Yesterday
September 01, 2021
Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it...
Via
Benzinga
Why Shares of Acasti Pharma Slumped Tuesday
August 31, 2021
The clinical-stage pharmaceutical company completed its merger with Grace Therapeutics last week.
Via
The Motley Fool
28 Stocks Moving in Monday's Pre-Market Session
August 30, 2021
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) rose 86.1% to $9.87 in pre-market trading after jumping over 80% on Friday. The company recently reported a Q2 loss of $5.13 per share...
Via
Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
August 25, 2021
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 40.1% to $21.43 in pre-market trading after gaining over 11% on Tuesday. Regencell Bioscience recently reported...
Via
Benzinga
26 Stocks Moving in Wednesday's Pre-Market Session
July 14, 2021
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) shares rose 35.6% to $3.54 in pre-market trading after jumping around 12% on Tuesday. Oxbridge Re Holdings Limited (NASDAQ: OXBR) shares...
Via
Benzinga
45 Biggest Movers From Yesterday
June 24, 2021
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613. First...
Via
Benzinga
31 Stocks Moving In Wednesday's Mid-Day Session
June 23, 2021
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613. Orphazyme A/S (NASDAQ: ORPH)...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.